Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Watson

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Gastroenterology Research|March 7, 2025
Analysis of Adverse Events of Endoscopic Ultrasound-Guided Lumen-Apposing Metal Stent Placement: Insights Across Various Indications and TechniquesMohammed Abusuliman, Taher Jamali, Faisal Nimri, et al.
Trials|March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trialTil Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
JCI Insight|March 23, 2018
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficienciesDavid A Slatter, Charles L Percy, Keith Allen-Redpath, et al.
Schizophrenia Research|July 4, 2025
Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: An umbrella trialPaul Hutton, Christopher D J Taylor, James Kelly, et al.
Pilot and Feasibility Studies|July 8, 2023
Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: a study protocol for a multi-site, assessor-blinded, pilot Umbrella trial (the DEC:IDES trial)Paul Hutton, James Kelly, Christopher D J Taylor, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Gastroenterology Research|March 7, 2025
Analysis of Adverse Events of Endoscopic Ultrasound-Guided Lumen-Apposing Metal Stent Placement: Insights Across Various Indications and TechniquesMohammed Abusuliman, Taher Jamali, Faisal Nimri, et al.
Trials|March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trialTil Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
JCI Insight|March 23, 2018
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficienciesDavid A Slatter, Charles L Percy, Keith Allen-Redpath, et al.
Schizophrenia Research|July 4, 2025
Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: An umbrella trialPaul Hutton, Christopher D J Taylor, James Kelly, et al.
Pilot and Feasibility Studies|July 8, 2023
Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: a study protocol for a multi-site, assessor-blinded, pilot Umbrella trial (the DEC:IDES trial)Paul Hutton, James Kelly, Christopher D J Taylor, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 14